| Emittent | Gattung | Typ | CUSIP/ISIN | Richtung | Bewertungsbasis | Handel | Bestand ($) | % NAV | Stück / Nennwert |
|---|---|---|---|---|---|---|---|---|---|
| 3.218.733.835 $ | 99,38 | 42.815.412 | |||||||
| UNITEDHEALTH GROUP INC | UNITEDHEALTH GROUP INC | EC | 91324P102 | Long | Börsenkurs (Stufe 1) | 265.455.000 $ | 8,20 | 900.000 | |
| ROCHE HOLDING LTD | ROCHE HOLDINGS AG (GENUSSCHEINE) | EC | CH0012032048 | Long | Modellwert (Stufe 2) | 200.940.732 $ | 6,20 | 580.000 | |
| HUMANA INC | HUMANA INC | EC | 444859102 | Long | Börsenkurs (Stufe 1) | 172.936.500 $ | 5,34 | 446.000 | |
| ASTRAZENECA PLC | ASTRAZENECA PLC | EC | GB0009895292 | Long | Modellwert (Stufe 2) | 162.356.047 $ | 5,01 | 1.560.000 | |
| REGENERON PHARMACEUTICALS INC | REGENERON PHARMACEUTICALS INC | EC | 75886F107 | Long | Börsenkurs (Stufe 1) | 162.149.000 $ | 5,01 | 260.000 | |
| CIGNA CORP | CIGNA CORP | EC | 125523100 | Long | Börsenkurs (Stufe 1) | 154.811.250 $ | 4,78 | 825.000 | |
| LILLY (ELI) and CO | LILLY (ELI) and CO | EC | 532457108 | Long | Börsenkurs (Stufe 1) | 152.687.400 $ | 4,71 | 930.000 | |
| BECTON DICKINSON and CO | BECTON DICKINSON and CO | EC | 075887109 | Long | Börsenkurs (Stufe 1) | 146.911.780 $ | 4,54 | 614.000 | |
| CENTENE CORP DEL | CENTENE CORP | EC | 15135B101 | Long | Börsenkurs (Stufe 1) | 115.661.000 $ | 3,57 | 1.820.000 | |
| BOSTON SCIENTIFIC CORP | BOSTON SCIENTIFIC CORP | EC | 101137107 | Long | Börsenkurs (Stufe 1) | 113.054.200 $ | 3,49 | 3.220.000 | |
| SANOFI | SANOFI | EC | FR0000120578 | Long | Modellwert (Stufe 2) | 101.984.691 $ | 3,15 | 1.000.000 | |
| INSULET CORP | INSULET CORP | EC | 45784P101 | Long | Börsenkurs (Stufe 1) | 75.761.400 $ | 2,34 | 390.000 | |
| VERTEX PHARMACEUTICALS INC | VERTEX PHARMACEUTICALS INC | EC | 92532F100 | Long | Börsenkurs (Stufe 1) | 74.319.360 $ | 2,29 | 256.000 | |
| PENUMBRA INC | PENUMBRA INC | EC | 70975L107 | Long | Börsenkurs (Stufe 1) | 71.367.062 $ | 2,20 | 399.100 | |
| DANAHER CORP | DANAHER CORP | EC | 235851102 | Long | Börsenkurs (Stufe 1) | 62.955.370 $ | 1,94 | 356.022 | |
| INTUITIVE SURGICAL INC | INTUITIVE SURGICAL INC | EC | 46120E602 | Long | Börsenkurs (Stufe 1) | 62.681.300 $ | 1,94 | 110.000 | |
| SAREPTA THERAPEUTICS INC | SAREPTA THERAPEUTICS INC | EC | 803607100 | Long | Börsenkurs (Stufe 1) | 55.156.960 $ | 1,70 | 344.000 | |
| ARGENX SE | ARGENX SE SPONSORED ADR | EC | 04016X101 | Long | Börsenkurs (Stufe 1) | 54.055.200 $ | 1,67 | 240.000 | |
| ASCENDIS PHARMA A/S | ASCENDIS PHARMA AS SPON ADR | EC | 04351P101 | Long | Börsenkurs (Stufe 1) | 50.700.120 $ | 1,57 | 342.800 | |
| MASIMO CORP | MASIMO CORP | EC | 574795100 | Long | Börsenkurs (Stufe 1) | 49.701.820 $ | 1,53 | 218.000 | |
| NEUROCRINE BIOSCIENCES INC | NEUROCRINE BIOSCIENCES INC | EC | 64125C109 | Long | Börsenkurs (Stufe 1) | 46.360.000 $ | 1,43 | 380.000 | |
| ALNYLAM PHARMACEUTICALS INC | ALNYLAM PHARMACEUTICALS INC | EC | 02043Q107 | Long | Börsenkurs (Stufe 1) | 44.433.000 $ | 1,37 | 300.000 | |
| LONZA GROUP AG | LONZA GROUP AG | EC | CH0013841017 | Long | Modellwert (Stufe 2) | 39.727.330 $ | 1,23 | 75.000 | |
| ANTHEM INC | ANTHEM INC | EC | 036752103 | Long | Börsenkurs (Stufe 1) | 39.447.000 $ | 1,22 | 150.000 | |
| BRUKER CORP | BRUKER CORP | EC | 116794108 | Long | Börsenkurs (Stufe 1) | 34.984.800 $ | 1,08 | 860.000 | |
| QUIDEL CORP | QUIDEL CORP | EC | 74838J101 | Long | Börsenkurs (Stufe 1) | 33.561.000 $ | 1,04 | 150.000 | |
| AMGEN INC | AMGEN INC | EC | 031162100 | Long | Börsenkurs (Stufe 1) | 32.076.960 $ | 0,99 | 136.000 | |
| ACCELERON PHARMA INC | ACCELERON PHARMA INC | EC | 00434H108 | Long | Börsenkurs (Stufe 1) | 31.439.100 $ | 0,97 | 330.000 | |
| BIONTECH SE | BIONTECH SE ADR | EC | 09075V102 | Long | Börsenkurs (Stufe 1) | 29.365.600 $ | 0,91 | 440.000 | |
| MYOKARDIA INC | MYOKARDIA INC | EC | 62857M105 | Long | Börsenkurs (Stufe 1) | 27.053.600 $ | 0,84 | 280.000 | |
| TANDEM DIABETES CARE INC | TANDEM DIABETES CARE INC | EC | 875372203 | Long | Börsenkurs (Stufe 1) | 24.730.000 $ | 0,76 | 250.000 | |
| INSPIRE MEDICAL SYSTEMS INC | INSPIRE MEDICAL SYSTEMS INC | EC | 457730109 | Long | Börsenkurs (Stufe 1) | 24.365.600 $ | 0,75 | 280.000 | |
| INNOVENT BIOLGICS INC | INNOVENT BIOLOGICS INC | EC | KYG4818G1010 | Long | Börsenkurs (Stufe 1) | 21.366.363 $ | 0,66 | 2.880.000 | |
| BEIGENE LTD | BEIGENE LTD SP ADR | EC | 07725L102 | Long | Börsenkurs (Stufe 1) | 18.840.000 $ | 0,58 | 100.000 | |
| VEEVA SYS INC | VEEVA SYS INC CL A | EC | 922475108 | Long | Börsenkurs (Stufe 1) | 18.753.600 $ | 0,58 | 80.000 | |
| NEKTAR THERAPEUTICS | NEKTAR THERAPEUTICS | EC | 640268108 | Long | Börsenkurs (Stufe 1) | 18.528.000 $ | 0,57 | 800.000 | |
| PRINCIPIA BIOPHARMA INC | PRINCIPIA BIOPHARMA INC | EC | 74257L108 | Long | Börsenkurs (Stufe 1) | 18.391.404 $ | 0,57 | 307.600 | |
| VIELA BIO INC | VIELA BIO INC | EC | 926613100 | Long | Börsenkurs (Stufe 1) | 17.328.000 $ | 0,53 | 400.000 | |
| ROYALTY PHARMA PLC | ROYALTY PHARMA PLC (180 DAY LOCKUP) | EC | Long | Schätzwert (Stufe 3) | 30.252.913 $ | 0,93 | 698.450 | ||
| ATRICURE INC | ATRICURE INC | EC | 04963C209 | Long | Börsenkurs (Stufe 1) | 16.631.500 $ | 0,51 | 370.000 | |
| 10X GENOMICS INC | 10X GENOMICS INC | EC | 88025U109 | Long | Börsenkurs (Stufe 1) | 15.932.904 $ | 0,49 | 178.400 | |
| REVOLUTION MEDICINES INC | REVOLUTION MEDICINES INC | EC | 76155X100 | Long | Börsenkurs (Stufe 1) | 15.785.000 $ | 0,49 | 500.000 | |
| DEXCOM INC | DEXCOM INC | EC | 252131107 | Long | Börsenkurs (Stufe 1) | 15.405.200 $ | 0,48 | 38.000 | |
| XENCOR INC | XENCOR INC | EC | 98401F105 | Long | Börsenkurs (Stufe 1) | 15.286.201 $ | 0,47 | 471.942 | |
| 1LIFE HEALTHCARE INC | 1LIFE HEALTHCARE INC (180 DAY LOCKUP) | EC | Long | Modellwert (Stufe 2) | 20.564.237 $ | 0,63 | 588.101 | ||
| INSMED INC | INSMED INC | EC | 457669307 | Long | Börsenkurs (Stufe 1) | 15.028.578 $ | 0,46 | 545.700 | |
| BLUEPRINT MEDICINES CORP | BLUEPRINT MEDICINES CORP | EC | 09627Y109 | Long | Börsenkurs (Stufe 1) | 12.480.000 $ | 0,39 | 160.000 | |
| TG THERAPEUTICS INC | TG THERAPEUTICS INC | EC | 88322Q108 | Long | Börsenkurs (Stufe 1) | 12.467.200 $ | 0,38 | 640.000 | |
| ZYMEWORKS INC | ZYMEWORKS INC | EC | 98985W102 | Long | Börsenkurs (Stufe 1) | 12.178.927 $ | 0,38 | 337.647 | |
| EBOS GROUP LTD | EBOS GROUP LTD | EC | NZEBOE0001S6 | Long | Börsenkurs (Stufe 1) | 11.797.413 $ | 0,36 | 846.000 | |
| ADC THERAPEUTICS SA | ADC THERAPEUTICS SA | EC | CH0499880968 | Long | Börsenkurs (Stufe 1) | 11.196.765 $ | 0,35 | 239.196 | |
| CLARIVATE PLC | CLARIVATE PLC | EC | JE00BJJN4441 | Long | Börsenkurs (Stufe 1) | 11.165.000 $ | 0,34 | 500.000 | |
| PLIANT THERAPEUTICS INC | PLIANT THERAPEUTICS INC | EC | 729139105 | Long | Börsenkurs (Stufe 1) | 11.036.400 $ | 0,34 | 340.000 | |
| THERAVANCE BIOPHARMA INC | THERAVANCE BIOPHARMA INC | EC | KYG8807B1068 | Long | Börsenkurs (Stufe 1) | 10.670.686 $ | 0,33 | 508.370 | |
| TURNING POINT THERAPEUTICS INC | TURNING POINT THERAPEUTICS INC | EC | 90041T108 | Long | Börsenkurs (Stufe 1) | 10.334.400 $ | 0,32 | 160.000 | |
| APREA THERAPEUTICS INC | APREA THERAPEUTICS INC | EC | 03836J102 | Long | Börsenkurs (Stufe 1) | 9.307.200 $ | 0,29 | 240.000 | |
| G1 THERAPEUTICS INC | G1 THERAPEUTICS INC | EC | 3621LQ109 | Long | Börsenkurs (Stufe 1) | 9.141.653 $ | 0,28 | 376.820 | |
| HARMONY BIOSCIENCES II INC | HARMONY BIOSCIENCES II INC SER A PC PP | EP | Long | Schätzwert (Stufe 3) | beschränkt | 12.324.024 $ | 0,38 | 5.092.572 | |
| ARCUTIS BIOTHERAPEUTICS INC | ARCUTIS BIOTHERAPEUTICS INC | EC | 03969K108 | Long | Börsenkurs (Stufe 1) | 8.467.200 $ | 0,26 | 280.000 | |
| ARVINAS INC | ARVINAS INC | EC | 04335A105 | Long | Börsenkurs (Stufe 1) | 8.385.000 $ | 0,26 | 250.000 | |
| KURA ONCOLOGY INC | KURA ONCOLOGY INC | EC | 50127T109 | Long | Börsenkurs (Stufe 1) | 8.150.000 $ | 0,25 | 500.000 | |
| ZENTALIS PHARMACEUTICALS INC | ZENTALIS PHARMACEUTICALS LLC | EC | 98943L107 | Long | Börsenkurs (Stufe 1) | 7.294.238 $ | 0,23 | 151.900 | |
| UNIQURE N.V. | UNIQURE N.V. | EC | NL0010696654 | Long | Börsenkurs (Stufe 1) | 7.209.600 $ | 0,22 | 160.000 | |
| ORIC PHARMACEUTICALS INC | ORIC PHARMACEUTICALS INC | EC | 68622P109 | Long | Börsenkurs (Stufe 1) | 7.043.229 $ | 0,22 | 208.812 | |
| POSEIDA THERAPEUTICS INC | POSEIDA THERAPEUTICS INC SER D PC PP | EP | Long | Schätzwert (Stufe 3) | beschränkt | 7.040.997 $ | 0,22 | 644.190 | |
| MODERNA INC | MODERNA INC | EC | 60770K107 | Long | Börsenkurs (Stufe 1) | 6.421.000 $ | 0,20 | 100.000 | |
| NEVRO CORP | NEVRO CORPORATION | EC | 64157F103 | Long | Börsenkurs (Stufe 1) | 5.734.560 $ | 0,18 | 48.000 | |
| SHOCKWAVE MEDICAL INC | SHOCKWAVE MEDICAL INC | EC | 82489T104 | Long | Börsenkurs (Stufe 1) | 5.519.316 $ | 0,17 | 116.515 | |
| REPARE THERAPEUTICS INC | REPARE THERAPEUTICS INC | EC | 760273102 | Long | Börsenkurs (Stufe 1) | 5.349.461 $ | 0,17 | 172.452 | |
| PASSAGE BIO INC | PASSAGE BIO INC | EC | 702712100 | Long | Börsenkurs (Stufe 1) | 5.174.608 $ | 0,16 | 189.338 | |
| BLACK DIAMOND THERAPEUTICS INC | BLACK DIAMOND THERAPEUTICS INC | EC | 09203E105 | Long | Börsenkurs (Stufe 1) | 5.059.200 $ | 0,16 | 120.000 | |
| INTERCEPT PHARMACEUTICALS INC | INTERCEPT PHARMACEUTICALS INC | EC | 45845P108 | Long | Börsenkurs (Stufe 1) | 4.791.000 $ | 0,15 | 100.000 | |
| FORMA THERAPEUTICS HOLDINGS | FORMA THERAPEUTICS HOLDINGS | EC | 34633R104 | Long | Börsenkurs (Stufe 1) | 4.463.040 $ | 0,14 | 96.000 | |
| DENALI THERAPEUTICS INC | DENALI THERAPEUTICS INC | EC | 24823R105 | Long | Börsenkurs (Stufe 1) | 3.385.200 $ | 0,10 | 140.000 | |
| OUTSET MEDICAL INC | OUTSET MEDICAL INC SER C PC PP | EP | Long | Schätzwert (Stufe 3) | beschränkt | 5.527.770 $ | 0,17 | 1.751.454 | |
| VAXCYTE INC | VAXCYTE INC | EC | 92243G108 | Long | Börsenkurs (Stufe 1) | 2.433.970 $ | 0,08 | 77.000 | |
| SAGE THERAPEUTICS INC | SAGE THERAPEUTICS INC | EC | 78667J108 | Long | Börsenkurs (Stufe 1) | 1.880.497 $ | 0,06 | 45.226 | |
| GENERATION BIO | GENERATION BIO | EC | 37148K100 | Long | Börsenkurs (Stufe 1) | 2.169.185 $ | 0,07 | 108.905 | |
| CASTLIGHT HEALTH INC | CASTLIGHT HEALTH INC | EC | 14862Q100 | Long | Börsenkurs (Stufe 1) | 1.402.036 $ | 0,04 | 1.689.200 | |
| FUSION PHARMACEUTICALS INC | FUSION PHARMACEUTICALS INC | EC | 36118A100 | Long | Börsenkurs (Stufe 1) | 448.979 $ | 0,01 | 25.700 | |
| 3.218.733.835 $ | 99,38 | 42.815.412 |